Postprandial effects of calcium phosphate supplementation on plasma concentration-double-blind, placebo-controlled cross-over human study

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Trautvetter, Ulrike ^a   Kiehntopf, Michael ^b   Jahreis, Gerhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Calcium phosphate; Human study; Plasma calcium; Plasma phosphate

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; PHOSPHORUS; PLACEBO;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FOOD INTAKE; HUMAN; MALE; PHOSPHATE BLOOD LEVEL; PLASMA CONCENTRATION-TIME CURVE; POSTPRANDIAL STATE;

ADULT; CALCIUM; CALCIUM PHOSPHATES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; INTERVENTION STUDIES; MALE; PHOSPHATES; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 84874684515     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-30     Document Type: Article

References (28)

1. Serum phosphate and mortality in patients with chronic kidney disease. Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, Hegarty J, New J, ODonoghue DJ, Middleton RJ, Kalra PA, Clin J Am Soc Nephrol 2010 5 2251 2257 10.2215/CJN.00810110 20688884
2. Association of serum phosphate with vascular and valvular calcification in moderate CKD. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR, J Am Soc Nephrol 2009 20 381 387 10.1681/ASN.2008040349 19073826
3. Cholesterol metabolism is affected by calcium phosphate supplementation in humans. Ditscheid B, Keller S, Jahreis G, J Nutr 2005 135 1678 1682 15987849 (Pubitemid 40980718)
4. High phosphorus intake only slightly affects serum minerals, urinary pyridinium crosslinks and renal function in young women. Grimm M, Muller A, Hein G, Funfstuck R, Jahreis G, Eur J Clin Nutr 2001 55 153 161 10.1038/sj.ejcn. 1601131 11305263 (Pubitemid 32171015)
5. A combination of calcium phosphate and probiotics beneficially influences intestinal lactobacilli and cholesterol metabolism in humans. Trautvetter U, Ditscheid B, Kiehntopf M, Jahreis G, Clin Nutr 2012 31 230 237 10.1016/j.clnu.2011.09.013 22019281
6. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Govers MJ, Van der Meer R, Gut 1993 34 365 370 10.1136/gut.34.3.365 8472985 (Pubitemid 23080263)
7. Mechanisms of the intestinal effects of dietary fats and milk products on colon carcinogenesis. Van der Meer R, Lapre JA, Govers M, Kleibeuker JH, Cancer Lett 1997 114 75 83 10.1016/S0304-3835(97)04629-6 9103258 (Pubitemid 27140079)
8. Protective effects of dietary lactulose and calcium phosphate against Salmonella infection. Bovee-Oudenhoven I, Van der Meer R, Scand J Gastroenterol Suppl 1997 222 112 114 9145462 (Pubitemid 27196275)
9. Faecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differences. Ditscheid B, Keller S, Jahreis G, Eur J Nutr 2009 48 22 30 10.1007/s00394-008-0755-2 19009227
10. Absorbability of calcium sources: the limited role of solubility. Heaney RP, Recker RR, Weaver CM, Calcif Tissue Int 1990 46 300 304 10.1007/BF02563819 2110852 (Pubitemid 20161770)
11. Calcium fortificants: Overview and strategies for improving calcium nutriture of the US population. Rafferty K, Walters G, Heaney RP, J Food Sci 2007 72 152 R158 10.1111/j.1750-3841.2007.00521.x 18034744 (Pubitemid 350150681)
12. Acute effect of high-calcium milk with or without additional magnesium, or calcium phosphate on parathyroid hormone and biochemical markers of bone resorption. Green JH, Booth C, Bunning R, Eur J Clin Nutr 2003 57 61 68 10.1038/sj.ejcn.1601501 12548298 (Pubitemid 36181796)
13. Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate. Hanzlik RP, Fowler SC, Fisher DH, J Pharmacol Exp Ther 2005 313 1217 1222 10.1124/jpet.104.081893 15734899 (Pubitemid 40727025)
14. Calcium fortification systems differ in bioavailability. Heaney RP, Rafferty K, Dowell MS, Bierman J, J Am Diet Assoc 2005 105 807 809 10.1016/j.jada.2005.02.012 15883561 (Pubitemid 40754451)
15. Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women. Heller HJ, Greer LG, Haynes SD, Poindexter JR, Pak CY, J Clin Pharmacol 2000 40 1237 1244 11075309
16. Pharmacokinetics of calcium absorption from two commercial calcium supplements. Heller HJ, Stewart A, Haynes S, Pak CY, J Clin Pharmacol 1999 39 1151 1154 10579145 (Pubitemid 30644017)
17. Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Ellam TJ, Chico TJ, Atherosclerosis 2012 220 310 318 10.1016/j.atherosclerosis.2011.09.002 21962238
18. Phosphate: a stealthier killer than previously thought? Gonzalez-Parra E, Tunon J, Egido J, Ortiz A, Cardiovasc Pathol 2012 21 372 381 10.1016/j.carpath.2012.02.008 22425627
19. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Uribarri J, Semin Dial 2007 20 295 301 10.1111/j.1525-139X.2007.00309.x 17635818
20. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Reginster JY, Denis D, Bartsch V, Deroisy R, Zegels B, Franchimont P, Osteoporos Int 1993 3 271 275 10.1007/BF01623832 8400610 (Pubitemid 23252447)
21. The absorption of tricalcium phosphate and its acute metabolic effects. Shires R, Kessler GM, Calcif Tissue Int 1990 47 142 144 10.1007/BF02555978 2171734 (Pubitemid 20300923)
22. The acute metabolic effects of oral tricalcium phosphate and calcium carbonate. Yang RS, Liu TK, Tsai KS, Calcif Tissue Int 1994 55 335 341 10.1007/BF00299310 7866912 (Pubitemid 24332738)
23. Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women. Karp HJ, Ketola ME, Lamberg-Allardt CJ, Br J Nutr 2009 102 1341 1347 10.1017/S0007114509990195 19538811
24. Consequences of phosphate imbalance. Berner YN, Shike M, Annu Rev Nutr 1988 8 121 148 10.1146/annurev.nu.08.070188.001005 3060161 (Pubitemid 19136321)
25. The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y, Inagaki N, Endocrinology 2008 149 574 579 18039776 (Pubitemid 351159357)
26. Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H, Endocrinology 2010 151 1473 1486 10.1210/en.2009-1272 20203154
27. Dietary calcium phosphate inhibits cytotoxicity of fecal water. Lapre JA, De Vries HT, Van der Meer R, Am J Physiol Gastrointest Liver Physiol 1991 261 907 912
28. Differential effects of calcium ions and calcium phosphate on cytotoxicity of bile acids. Van der Meer R, Termont DS, De Vries HT, Am J Physiol 1991 260 142 147 1987802